Glucocorticoid receptors in lung cancer: new perspectives

  1. Paula Sommer1⇑
  1. 1Division of Genetics, School of Life Sciences, University of KwaZulu-Natal, Durban, South Africa
  2. 2Manchester Centre for Nuclear Hormone Research and Disease, Institute of Human Development, Faculty of Medical and Human Sciences, University of Manchester, Manchester, United Kingdom
  1. Correspondence should be addressed to P Sommer; Email: Sommerp{at}ukzn.ac.za
  1. View larger version:
    Figure 1

    Summary of the effects of Gc monotherapy (A) and co-treatment (B) on lung cancer in in vitro, in xenograft, chemically-induced mouse models and in vivo situations. Dex, dexamethasone; Bud, budesonide; COPD, chronic obstructive pulmonary disease.

| Table of Contents

This Article

  1. Published online before print January 21, 2016, doi: 10.1530/JOE-15-0496 J Endocrinol 229 R17-R28
  1. AbstractFree
  2. Figures Only
  3. Full Text
  4. Full Text (PDF)
  5. All Versions of this Article:
    1. JOE-15-0496v1
    2. 229/1/R17 most recent

Article Metrics

  1. Article Usage Statistics

Current Issue

  1. December 2017, 235 (3)
  1. Current Issue
  1. Alert me to new issues of Journal of Endocrinology

Most